Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 32.08% vs 2.27% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 101.10% vs -1,392.79% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "256.10",
          "val2": "193.90",
          "chgp": "32.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.20",
          "val2": "-253.60",
          "chgp": "109.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "21.80",
          "val2": "28.40",
          "chgp": "-23.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.40",
          "val2": "-310.50",
          "chgp": "101.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.60%",
          "val2": "-1,398.80%",
          "chgp": "149.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -15.17% vs -26.46% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -39.20% vs 78.85% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "873.70",
          "val2": "1,029.90",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-192.10",
          "val2": "-128.20",
          "chgp": "-49.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "99.50",
          "val2": "105.20",
          "chgp": "-5.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.50",
          "val2": "33.60",
          "chgp": "-107.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-367.50",
          "val2": "-264.00",
          "chgp": "-39.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-301.90%",
          "val2": "-197.10%",
          "chgp": "-10.48%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

256.10

193.90

32.08%

Operating Profit (PBDIT) excl Other Income

24.20

-253.60

109.54%

Interest

21.80

28.40

-23.24%

Exceptional Items

0.00

0.00

Consolidate Net Profit

3.40

-310.50

101.10%

Operating Profit Margin (Excl OI)

94.60%

-1,398.80%

149.34%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 32.08% vs 2.27% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 101.10% vs -1,392.79% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

873.70

1,029.90

-15.17%

Operating Profit (PBDIT) excl Other Income

-192.10

-128.20

-49.84%

Interest

99.50

105.20

-5.42%

Exceptional Items

-2.50

33.60

-107.44%

Consolidate Net Profit

-367.50

-264.00

-39.20%

Operating Profit Margin (Excl OI)

-301.90%

-197.10%

-10.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -15.17% vs -26.46% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -39.20% vs 78.85% in Dec 2024

All Annual Results